Bone Changes During Growth in Patients with Osteogenesis Imperfecta

被引:0
|
作者
Burgueno-Torres, Laura [1 ]
Garcia-Boedo, Lara [1 ]
de Nova-Garcia, Manuel Joaquin [1 ]
机构
[1] Univ Complutense Madrid, Fac Dent, Dent Clin Specialties Dept, Madrid 28040, Spain
关键词
osteogenesis imperfecta; biphosphonates; orthopantomography; panoramic index; pediatric patient; PANORAMIC MANDIBULAR INDEXES; RADIOMORPHOMETRIC INDEXES; FRACTAL DIMENSION; CHILDREN; PAMIDRONATE; THERAPY; DENSITY; DIAGNOSIS; GENDER; CORTEX;
D O I
10.3390/jcm14051764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: Osteogenesis Imperfecta (OI) is a congenital disorder, in which the production of collagen, mainly type I, is altered, leading to a decrease in bone mineral density, increasing the risk of fracture with minimal trauma. Several studies have analyzed bone mineral density in osteoporotic patients based on linear measurements such as radiomorphometric indices measured with panoramic radiographs, although few studies have investigated bone trabeculation in children diagnosed with OI. Therefore, the aim of the present investigation was to analyze the dental panoramic indices in panoramic radiographs in the cortical and trabeculated bone of children with OI. Methods: Thus, 66 pediatric patients diagnosed with OI under antiresorptive treatment were compared with a sample of controls matched for sex and age. Using Image J software (version: 1.54d), three radiomorphometric indices were analyzed in orthopantomographies of the study and control groups, evaluating the influence of disease severity as well as the type of antiresorptive treatment administered. Results: Patients with OI had a higher presence of type C2 and C3 MCI (mandibular cortical index) than their matched controls (p < 0.05), although no differences were found for the visual estimation of cortical width (SVE) and mandibular cortical width (MCW). Treatment with zoledronic acid was associated with a higher number of cases of type C1 MCI, in terms of sample description, while patients treated with a combination of pamidronate and zoledronic acid had a higher rate of type C1 and C2 MCI, with no statistical differences. Conclusions: In the overall sample, most patients showed a thin SVE index (59.1%), a C2 or C1 type MCI (46.2% and 42.4%) and an MCW of 2.9 mm. Differences in bone mineral density were also observed throughout growth and the different antiresorptive treatments. Zoledronic acid has been associated with a higher percentage of C1 and C3 ICM, and pamidronate alone or in combination is associated with a C1 and C2 MCI index.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Osteogenesis imperfecta in Brazilian patients
    Trancozo, Maira
    Moraes, Marcos V. D.
    Silva, Dalila A.
    Soares, Jessica A. M.
    Barbirato, Clara
    Almeida, Marcio G.
    Santos, Ligia R.
    Reboucas, Maria R. G. O.
    Akel, Akel N., Jr.
    Sipolatti, Valentim
    Nunes, Vanda R. R.
    Errera, Flavia I., V
    Aguena, Meire
    Passos-Bueno, Maria R.
    de Paula, Flavia
    GENETICS AND MOLECULAR BIOLOGY, 2019, 42 (02) : 344 - 350
  • [42] Anthropometry of patients with osteogenesis imperfecta
    Lund, AM
    Müller, J
    Skovby, F
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (06) : 524 - 528
  • [43] OSTEOGENESIS IMPERFECTA AND OSTEOGENESIS IMPERFECTA CYSTICA
    FAIRBANK, HAT
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1948, 30 (01): : 164 - 186
  • [44] Application of Orthopantomography in the Analysis of Bone Mineral Density in Patients with Osteogenesis Imperfecta
    Garcia-Boedo, Lara
    Burgueno-Torres, Laura
    de Nova-Garcia, Manuel Joaquin
    APPLIED SCIENCES-BASEL, 2024, 14 (05):
  • [45] EVALUATION OF PATIENTS WITH OSTEOGENESIS IMPERFECTA TREATED ON A BONE FRAGILITY OUTPATIENT CLINIC
    Oliveira, T. P.
    Peters, B. S. E.
    Muszkat, P.
    Barros, E. R.
    Bonansea, T. C. P.
    Weiler, F. G.
    Foroni, M. Z.
    Lazaretti-Castro, M.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S515 - S516
  • [46] Skewfoot in patients with osteogenesis imperfecta
    Mirzayan, R
    Cepkinian, V
    Yu, J
    Wellisch, MD
    Zionts, LE
    FOOT & ANKLE INTERNATIONAL, 2000, 21 (09) : 768 - 771
  • [47] Stapedotomy in osteogenesis imperfecta patients
    Ferekidis, E
    Stavroulaki, P
    Vossinakis, I
    Yiotakis, J
    Manolopoulos, L
    Adamopoulos, G
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2000, 114 (06): : 424 - 428
  • [48] STUDIES OF PATIENTS WITH OSTEOGENESIS IMPERFECTA
    ALBRIGHT, JA
    GRUNT, JA
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1971, A 53 (07): : 1415 - +
  • [49] The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta
    Ipach, Ingmar
    Kluba, Torsten
    Wolf, Petra
    Pontz, Bertram
    Mittag, Falk
    ORTHOPEDIC REVIEWS, 2012, 4 (03) : 128 - 133
  • [50] Assessment of longitudinal bone growth in osteogenesis imperfecta using metacarpophalangeal pattern profiles
    Rauch, Damian
    Robinson, Marie-Eve
    Seiltgens, Cristian
    Sutton, V. Reid
    Lee, Brendan
    Glorieux, Francis
    Rauch, Frank
    BONE, 2020, 140